As part of Nestlé, Purina draws on the unequaled culture collection and decades of microbiome, prebiotic and probiotic research to evaluate potential probiotic strains of value to veterinary medicine and pet health.
Nestlé has been collecting bacterial strains since the 1970s. The Nestlé Culture Collection (NCC), housed in Lausanne, Switzerland, contains thousands of bacterial strains that have been genetically sequenced and cataloged.
Nestlé published the first Bifidobacterium species genome sequence as well as the first Lactobacillus species sequenced from the human gut.1,2
Purina and Nestlé scientists collaborated on the first direct comparison of the dog and human microbiomes. This was the first study to demonstrate the similarity between the microbiomes of the two species as well as the similarity in their responses to diet.11,12
Purina was the first to offer a shelf-stable probiotic supplement proven to promote a healthy immune system and provide dietary management of dogs or cats with diarrhea. This probiotic, a specific strain of Enterococcus faecium called E. faecium SF68 (NCIMB 10415 4b1705), remains the most studied probiotic in veterinary medicine based on publications to date. Purina was also the first to offer a shelf-stable probiotic (Bifidobacterium longum BL999, NCC 3001) proven to reduce some anxious behaviors and help dogs cope with external stressors. In addition to product development-focused research, Purina performs and funds research that advances scientific knowledge of the microbiome health and the impact of nutrition.
The Nestlé Nutrition Institute is a not-for-profit association established in 1981 with the goal to advance the science of nutrition. Visit their website for more information and resources.
This document provides summaries of published Purina science related to the microbiome.
This document presents Purina’s published microbiome science into clinical context for veterinarians.